Effects of L-arginine supplementation on endothelial function after stent implantation;Systemowo podawana L-arginina a funkcja śródblłonka naczyniowego po implantacji stentu

Kardiologia Polska

Volumn 57, Issue 11, 2002, Pages 389-397

  Dudek, Dariusz ^a   Heba, Grzegorz ^a   Bartuś, Stanisław ^a   Partyka, Łukasz ^a   Dembińska Kieć, Aldona ^a   Huk, Jhor ^b   Legutko, Jacek ^a   Dubiel, Jacek S ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Endothelial markers; In stent restenosis; L arginine; Nitric oxide

Indexed keywords

ARGININE; ENDOTHELIN; GROWTH FACTOR; PLACEBO; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ADULT; AGED; ARTICLE; BIOCHEMISTRY; BLOOD LEVEL; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; HUMAN; IMPLANTATION; INTIMA; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; SINGLE BLIND PROCEDURE;

EID: 17144469043     PISSN: 00229032     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Wolf A., Zalpour C., Theilmeier G. et al.: Dietary L-arginine supplementation normalized platelet aggregation in hypercholesterolemic humans. J. Am. Coll. Cardiol. 1997, 29, 479-485.
2. Garg U.C., Hassid A.: Nitric oxide-generating vasodilators and 8-bromocyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J. Clin. Invest. 1989, 83, 1774-1777.
3. Dudek D., Partyka L., Bartuś S. et al.: Effect of L-arginine and tetrahydrobiopterin (BH4) supplementation on the neointimal formation after balloon arterial injury. Am. J. Cardiol., 1999, 84, Suppl. 6A, 63P.
4. Huk I., Nanobashvili J., Neumayer C. et al.: L-arginine treatment alters the kinetics of nitric oxide and superoxide release and reduces ischemia/reperfusion injury in skeletal muscle. Circulation 1997 Jul. 15, 96(2), 667-75.
5. Hoffmann R., Mintz G.S., Dussaillant G.R.: Patterns and mechanisms of in-stent restenosis a serial intravascular ultrasound study. Circulation 1996, 94, 1247-1254.
6. Grewe P.H., Deneke T., Machraoui A. et al.: Acute and chronic tissue response to coronary stent implantation: Pathologic findings in human specimen. J. Am. Coll. Cardiol. 2000, 35, 157-63.
7. Boger R.H., Bode-Boger S.M., Kienke S. et al.: Dietary L-arginine decreases myointimal cell proliferation and vascular monocyte accumulation in cholesterol-fed rabbits. Atherosclerosis 1998, 136, 67-77.
8. Schwarzacher S.P., Lim T.T., Wang B. et al.: Local intramural delivery of L-arginine enhances nitric oxide generation and inhibits lesion formation after balloon angioplasty. Circulation 1997, 95, 1863-9.
9. Niebauer J., Schwarzacher S.P., Hayase M. et al.: Local L-arginine delivery after balloon angioplasty reduces monocyte binding and induces apoptosis. Circulation 1999, 100, 1830-1835.
10. Laitinen M., Zachary I., Breier G. et al.: VEGF gene transfer reduces intimal thickening via increased production of nitric oxide in carotid arteries. Hum. Gene. Ther. 1997, 8, 1737-1744.
11. Kasama T., Kobayashi K., Yajima N. et al.: Expression of vascular endothelial growth factor by synovial fluid neutrophils in rheumatoid arthritis (RA). Clin. Exp. Immunol. 2000, 121, 533-8.
12. Ohlstein E.H., Douglas SA.: Endothelin-1 modulates vascular smooth muscle structure and vasomotion: Implications in cardiovascular pathology. Drug Dev. Res. 1993, 29, 108-128.
13. Verghese M., Hasdai D., Lerman A.: The role of endothelin in coronary atherosclerosis. Mayo. Clinic. Proceedings 1996, 71, 769-777.
14. Hahn A.W., Resink T.J., Scott-Burden T. et al.: Stimulation of endothelin mRNA and secretion in rat vascular smooth muscle cells: A novel autocrine function. Cell Regul. 1990, 1, 649-659.
15. Trachtenberg J.D., Sun S., Choi E.T. et al.: Effect of endothelin-1 infusion on the development of intimal hyperplasia after balloon catheter injury. J. Cardiovasc. Pharmacol. 1993, 22 (suppl 8), S355-S359.
16. Nikol S., Isner M., Pickering J.G. et al.: Expression of transforming growth factor-[beta]1 is increased in human vascular restenosis lesions. J. Clin. Invest. 1992, 90, 1582-1592.
17. Yutani C., Ishibashi-Ueda H., Suzuki T. et al.: Histologic evidence of foreign body granulation tissue and de novo lesions in patients with coronary stent restenosis. Cardiology 1999, 92, 171-7.
18. Suzuki T., Hayase M., Hibi K.: Effect of local delivery of L-arginine on in-stent restenosis in humans. Am. J. Cardiol. 2002, 89, 363-367.
19. Six I., Van Belle E., Bordet R.: L-arginine and L-NAME have no effects on the reendothelialization process after arterial balloon injury. Cardiovasc. Res. 1999, 43, 731-8.
20. Blum A., Hathaway L., Mincemoyer R.: Oral L-arginine in patients with coronary artery disease on medical management. Circulation 2000, 101, 2160-4.